Regional Anesthesia in the Anticoagulated Patient: Defining the Risks

Terese T. Horlocker, Denise J. Wedel, Honorio Benzon, David L. Brown, Kayser F. Enneking, John A. Heit, Michael F. Mulroy, Richard W. Rosenquist, John Rowlingson, Michael Tryba, Chun Su Yuan

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Practice guidelines or recommendations summarize evidence-based reviews. However, the rarity of spinal hematoma defies a prospective-randomized study, and there is no current laboratory model. As a result, these Consensus Statements represent the collective experience of recognized experts in the field of neuraxial anesthesia and anticoagulation. They are based on case reports, clinical series, pharmacology, hematology, and risk factors for surgical bleeding. An understanding of the complexity of this issue is essential to patient management; a "cook-book" approach is not appropriate. Rather, the decision to perform spinal or epidural anesthesia/analgesia and the timing of catheter removal in a patient receiving antithrombotic therapy should be made on an individual basis, weighing the small, though definite risk of spinal hematoma with the benefits of regional anesthesia for a specific patient. Alternative anesthetic and analgesic techniques exist for patients considered an unacceptable risk. The patient's coagulation status should be optimized at the time of spinal or epidural needle/catheter placement, and the level of anticoagulation must be carefully monitored during the period of epidural catheterization. Indwelling catheters should not be removed in the presence of therapeutic anticoagulation because this appears to significantly increase the risk of spinal hematoma. It must also be remembered that identification of risk factors and establishment of guidelines will not completely eliminate the complication of spinal hematoma. Vigilance in monitoring is critical to allow early evaluation of neurologic dysfunction and prompt intervention. We must focus not only on the prevention of spinal hematoma, but also optimization of neurologic outcome.

Original languageEnglish (US)
Pages (from-to)1-11
Number of pages11
JournalRegional Anesthesia and Pain Medicine
Volume29
Issue number2 SUPPL. 2
DOIs
StatePublished - Mar 2004

Fingerprint

Conduction Anesthesia
Hematoma
Catheters
Anesthesia and Analgesia
Indwelling Catheters
Epidural Analgesia
Clinical Pharmacology
Epidural Anesthesia
Spinal Anesthesia
Hematology
Neurologic Manifestations
Practice Guidelines
Catheterization
Nervous System
Needles
Analgesics
Anesthetics
Anesthesia
Prospective Studies
Guidelines

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Horlocker, T. T., Wedel, D. J., Benzon, H., Brown, D. L., Enneking, K. F., Heit, J. A., ... Yuan, C. S. (2004). Regional Anesthesia in the Anticoagulated Patient: Defining the Risks. Regional Anesthesia and Pain Medicine, 29(2 SUPPL. 2), 1-11. https://doi.org/10.1016/j.rapm.2003.12.006

Regional Anesthesia in the Anticoagulated Patient : Defining the Risks. / Horlocker, Terese T.; Wedel, Denise J.; Benzon, Honorio; Brown, David L.; Enneking, Kayser F.; Heit, John A.; Mulroy, Michael F.; Rosenquist, Richard W.; Rowlingson, John; Tryba, Michael; Yuan, Chun Su.

In: Regional Anesthesia and Pain Medicine, Vol. 29, No. 2 SUPPL. 2, 03.2004, p. 1-11.

Research output: Contribution to journalArticle

Horlocker, TT, Wedel, DJ, Benzon, H, Brown, DL, Enneking, KF, Heit, JA, Mulroy, MF, Rosenquist, RW, Rowlingson, J, Tryba, M & Yuan, CS 2004, 'Regional Anesthesia in the Anticoagulated Patient: Defining the Risks', Regional Anesthesia and Pain Medicine, vol. 29, no. 2 SUPPL. 2, pp. 1-11. https://doi.org/10.1016/j.rapm.2003.12.006
Horlocker TT, Wedel DJ, Benzon H, Brown DL, Enneking KF, Heit JA et al. Regional Anesthesia in the Anticoagulated Patient: Defining the Risks. Regional Anesthesia and Pain Medicine. 2004 Mar;29(2 SUPPL. 2):1-11. https://doi.org/10.1016/j.rapm.2003.12.006
Horlocker, Terese T. ; Wedel, Denise J. ; Benzon, Honorio ; Brown, David L. ; Enneking, Kayser F. ; Heit, John A. ; Mulroy, Michael F. ; Rosenquist, Richard W. ; Rowlingson, John ; Tryba, Michael ; Yuan, Chun Su. / Regional Anesthesia in the Anticoagulated Patient : Defining the Risks. In: Regional Anesthesia and Pain Medicine. 2004 ; Vol. 29, No. 2 SUPPL. 2. pp. 1-11.
@article{a9edd6232c6f4c9a80eb6017dd762f8b,
title = "Regional Anesthesia in the Anticoagulated Patient: Defining the Risks",
abstract = "Practice guidelines or recommendations summarize evidence-based reviews. However, the rarity of spinal hematoma defies a prospective-randomized study, and there is no current laboratory model. As a result, these Consensus Statements represent the collective experience of recognized experts in the field of neuraxial anesthesia and anticoagulation. They are based on case reports, clinical series, pharmacology, hematology, and risk factors for surgical bleeding. An understanding of the complexity of this issue is essential to patient management; a {"}cook-book{"} approach is not appropriate. Rather, the decision to perform spinal or epidural anesthesia/analgesia and the timing of catheter removal in a patient receiving antithrombotic therapy should be made on an individual basis, weighing the small, though definite risk of spinal hematoma with the benefits of regional anesthesia for a specific patient. Alternative anesthetic and analgesic techniques exist for patients considered an unacceptable risk. The patient's coagulation status should be optimized at the time of spinal or epidural needle/catheter placement, and the level of anticoagulation must be carefully monitored during the period of epidural catheterization. Indwelling catheters should not be removed in the presence of therapeutic anticoagulation because this appears to significantly increase the risk of spinal hematoma. It must also be remembered that identification of risk factors and establishment of guidelines will not completely eliminate the complication of spinal hematoma. Vigilance in monitoring is critical to allow early evaluation of neurologic dysfunction and prompt intervention. We must focus not only on the prevention of spinal hematoma, but also optimization of neurologic outcome.",
author = "Horlocker, {Terese T.} and Wedel, {Denise J.} and Honorio Benzon and Brown, {David L.} and Enneking, {Kayser F.} and Heit, {John A.} and Mulroy, {Michael F.} and Rosenquist, {Richard W.} and John Rowlingson and Michael Tryba and Yuan, {Chun Su}",
year = "2004",
month = "3",
doi = "10.1016/j.rapm.2003.12.006",
language = "English (US)",
volume = "29",
pages = "1--11",
journal = "Regional Anesthesia and Pain Medicine",
issn = "1098-7339",
publisher = "Lippincott Williams and Wilkins",
number = "2 SUPPL. 2",

}

TY - JOUR

T1 - Regional Anesthesia in the Anticoagulated Patient

T2 - Defining the Risks

AU - Horlocker, Terese T.

AU - Wedel, Denise J.

AU - Benzon, Honorio

AU - Brown, David L.

AU - Enneking, Kayser F.

AU - Heit, John A.

AU - Mulroy, Michael F.

AU - Rosenquist, Richard W.

AU - Rowlingson, John

AU - Tryba, Michael

AU - Yuan, Chun Su

PY - 2004/3

Y1 - 2004/3

N2 - Practice guidelines or recommendations summarize evidence-based reviews. However, the rarity of spinal hematoma defies a prospective-randomized study, and there is no current laboratory model. As a result, these Consensus Statements represent the collective experience of recognized experts in the field of neuraxial anesthesia and anticoagulation. They are based on case reports, clinical series, pharmacology, hematology, and risk factors for surgical bleeding. An understanding of the complexity of this issue is essential to patient management; a "cook-book" approach is not appropriate. Rather, the decision to perform spinal or epidural anesthesia/analgesia and the timing of catheter removal in a patient receiving antithrombotic therapy should be made on an individual basis, weighing the small, though definite risk of spinal hematoma with the benefits of regional anesthesia for a specific patient. Alternative anesthetic and analgesic techniques exist for patients considered an unacceptable risk. The patient's coagulation status should be optimized at the time of spinal or epidural needle/catheter placement, and the level of anticoagulation must be carefully monitored during the period of epidural catheterization. Indwelling catheters should not be removed in the presence of therapeutic anticoagulation because this appears to significantly increase the risk of spinal hematoma. It must also be remembered that identification of risk factors and establishment of guidelines will not completely eliminate the complication of spinal hematoma. Vigilance in monitoring is critical to allow early evaluation of neurologic dysfunction and prompt intervention. We must focus not only on the prevention of spinal hematoma, but also optimization of neurologic outcome.

AB - Practice guidelines or recommendations summarize evidence-based reviews. However, the rarity of spinal hematoma defies a prospective-randomized study, and there is no current laboratory model. As a result, these Consensus Statements represent the collective experience of recognized experts in the field of neuraxial anesthesia and anticoagulation. They are based on case reports, clinical series, pharmacology, hematology, and risk factors for surgical bleeding. An understanding of the complexity of this issue is essential to patient management; a "cook-book" approach is not appropriate. Rather, the decision to perform spinal or epidural anesthesia/analgesia and the timing of catheter removal in a patient receiving antithrombotic therapy should be made on an individual basis, weighing the small, though definite risk of spinal hematoma with the benefits of regional anesthesia for a specific patient. Alternative anesthetic and analgesic techniques exist for patients considered an unacceptable risk. The patient's coagulation status should be optimized at the time of spinal or epidural needle/catheter placement, and the level of anticoagulation must be carefully monitored during the period of epidural catheterization. Indwelling catheters should not be removed in the presence of therapeutic anticoagulation because this appears to significantly increase the risk of spinal hematoma. It must also be remembered that identification of risk factors and establishment of guidelines will not completely eliminate the complication of spinal hematoma. Vigilance in monitoring is critical to allow early evaluation of neurologic dysfunction and prompt intervention. We must focus not only on the prevention of spinal hematoma, but also optimization of neurologic outcome.

UR - http://www.scopus.com/inward/record.url?scp=12144289711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12144289711&partnerID=8YFLogxK

U2 - 10.1016/j.rapm.2003.12.006

DO - 10.1016/j.rapm.2003.12.006

M3 - Article

AN - SCOPUS:12144289711

VL - 29

SP - 1

EP - 11

JO - Regional Anesthesia and Pain Medicine

JF - Regional Anesthesia and Pain Medicine

SN - 1098-7339

IS - 2 SUPPL. 2

ER -